These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: [Interdisciplinary recommendations on targeted therapy in the treatment of renal cell carcinoma]. Author: Miller K, Bergmann L, Albers P, Jäger E, Jakse G, Geschwend JE, Marschner N. Journal: Aktuelle Urol; 2007 Jul; 38(4):328-30. PubMed ID: 17647172. Abstract: Recently, new data have been published on the treatment of metastasized renal cell cancer using targeted therapies. With the approval of the tyrosine kinase inhibitors Sunitinib and Sorafenib, two of these new therapies are now available in clinical practice. This has raised both new opportunities and new questions for the health care professionals involved. Here we report on a consensus conference addressing these questions with answers based on evidence from the recent literature.[Abstract] [Full Text] [Related] [New Search]